Unknown

Dataset Information

0

Codominant IgG and IgA expression with minimal vaccine mRNA in milk of BNT162b2 vaccinees.


ABSTRACT: Lactating women can produce protective antibodies in their milk after vaccination, which has informed antenatal vaccination programs for diseases such as influenza and pertussis. However, whether SARS-CoV-2-specific antibodies are produced in human milk as a result of COVID-19 vaccination is still unclear. In this study, we show that lactating mothers who received the BNT162b2 vaccine secreted SARS-CoV-2-specific IgA and IgG antibodies into milk, with the most significant increase at 3-7 days post-dose 2. Virus-specific IgG titers were stable out to 4-6 weeks after dose 2. In contrast, SARS-CoV-2-specific IgA levels showed substantial decay. Vaccine mRNA was detected in few milk samples (maximum of 2 ng/ml), indicative of minimal transfer. Additionally, infants who consumed post-vaccination human milk had no reported adverse effects up to 28 days post-ingestion. Our results define the safety and efficacy profiles of the vaccine in this demographic and provide initial evidence for protective immunity conferred by milk-borne SARS-CoV-2-specific antibodies. Taken together, our study supports recommendations for uninterrupted breastfeeding subsequent to mRNA vaccination against COVID-19.

SUBMITTER: Low JM 

PROVIDER: S-EPMC8376902 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8553805 | biostudies-literature
| S-EPMC9283125 | biostudies-literature
| S-EPMC10675463 | biostudies-literature
| S-EPMC7938284 | biostudies-literature
| S-EPMC8208542 | biostudies-literature
2024-04-22 | GSE209985 | GEO
| S-EPMC6314215 | biostudies-literature
| S-EPMC7745181 | biostudies-literature
| S-EPMC8008751 | biostudies-literature
| S-EPMC8531987 | biostudies-literature